The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy
Open accessAbstract
Background: Curcumin, a yellow polyphenol extracted from the rhizome of turmeric (Curcuma longa), has potent anti-cancer properties as demonstrated in a plethora of human cancer cell line and animal carcinogenesis models. Nevertheless, widespread clinical application of this relatively efficacious agent in cancer and other diseases has been limited due to poor aqueous solubility, and consequently, minimal systemic bioavailability. Nanoparticle-based drug delivery approaches have the potential for rendering hydrophobic agents like curcumin dispersible in aqueous media, thus circumventing the pitfalls of poor solubility. Results: We have synthesized polymeric nanoparticle encapsulated formulation of curcumin – nanocurcumin – utilizing the micellar aggregates of cross-linked and random copolymers of N-isopropylacrylamide (NIPAAM), with N-vinyl-2-pyrrolidone (VP) and poly(ethyleneglycol)monoacrylate (PEG-A). Physico-chemical characterization of the polymeric nanoparticles by dynamic laser light scattering and transmission electron microscopy confirms a narrow size distribution in the 50 nm range. Nanocurcumin, unlike free curcumin, is readily dispersed in aqueous media. Nanocurcumin demonstrates comparable in vitro therapeutic efficacy to free curcumin against a panel of human pancreatic cancer cell lines, as assessed by cell viability and clonogenicity assays in soft agar. Further, nanocurcumin's mechanisms of action on pancreatic cancer cells mirror that of free curcumin, including induction of cellular apoptosis, blockade of nuclear factor kappa B (NFκB) activation, and downregulation of steady state levels of multiple pro-inflammatory cytokines (IL-6, IL-8, and TNFα). Conclusion: Nanocurcumin provides an opportunity to expand the clinical repertoire of this efficacious agent by enabling ready aqueous dispersion. Future studies utilizing nanocurcumin are warranted in pre-clinical in vivo models of cancer and other diseases that might benefit from the effects of curcumin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wang, Z., Zhang, Y., Banerjee, S., Li, Y., & Sarkar, F. H. (2006) · Cancer · doi:10.1002/cncr.21904 · Cited by 263
RetractedBiodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Anticancer potential of curcumin: preclinical and clinical studies.
Aggarwal, B. B., Kumar, A. J., & Bharti, A. C. (2003) · PubMed · Cited by 2,550
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336
Micellar Nanocarriers: Pharmaceutical Perspectives
Torchilin, V. P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9132-0 · Cited by 1,910
Molecular targets of dietary agents for prevention and therapy of cancer
Aggarwal, B. B., & Shishodia, S. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.02.009 · Cited by 1,754
Multiple biological activities of curcumin: A short review
Maheshwari, R. K., Singh, A. K., Gaddipati, J., & Srimal, R. C. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.12.007 · Cited by 1,674
Lim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A., & Cole, G. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08370.2001 · Cited by 1,530
Block copolymer micelles: preparation, characterization and application in drug delivery
Gaucher, G., Dufresne, M.-H., Sant, V. P., Kang, N., Maysinger, D., & Leroux, J.-C. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.034 · Cited by 1,498
Dose escalation of a curcuminoid formulation
Lao, C. D., Ruffin, M. T., Normolle, D., Heath, D. D., Murray, S. I., Bailey, J. M., Boggs, M. E., Crowell, J., Rock, C. L., & Brenner, D. E. (2006) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-6-10 · Cited by 1,394
Phase I Clinical Trial of Oral Curcumin
Sharma, R. A., Euden, S. A., Platton, S. L., Cooke, D. N., Shafayat, A., Hewitt, H. R., Marczylo, T. H., Morgan, B., Hemingway, D., Plummer, S. M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0744 · Cited by 1,257
Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro
Ono, K., Hasegawa, K., Naiki, H., & Yamada, M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20025 · Cited by 1,254
Chemopreventive and therapeutic effects of curcumin
Duvoix, A., Blasius, R., Delhalle, S., Schnekenburger, M., Morceau, F., Henry, E., Dicato, M., & Diederich, M. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.09.041 · Cited by 866
Curcumin: Getting Back to the Roots
SHISHODIA, S., SETHI, G., & AGGARWAL, B. B. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1352.010 · Cited by 715
Albumin-bound paclitaxel: a next-generation taxane
Gradishar, W. J. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.8.1041 · Cited by 712
Li, L., Braiteh, F. S., & Kurzrock, R. (2005) · Cancer · doi:10.1002/cncr.21300 · Cited by 644
Kawamori, T., Lubet, R., Steele, V. E., Kelloff, G. J., Kaskey, R. B., Rao, C. V., & Reddy, B. S. (1999) · PubMed · Cited by 589
Aggarwal, B. B., Shishodia, S., Takada, Y., Banerjee, S., Newman, R. A., Bueso-Ramos, C. E., & Price, J. E. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1192 · Cited by 584
Curcumin, a Major Constituent of Turmeric, Corrects Cystic Fibrosis Defects
Egan, M. E., Pearson, M., Weiner, S. A., Rajendran, V., Rubin, D., Glöckner-Pagel, J., Canny, S., Du, K., Lukacs, G. L., & Caplan, M. J. (2004) · Science · doi:10.1126/science.1093941 · Cited by 562
Targeted polymeric micelles for delivery of poorly soluble drugs
Torchilin, V. P. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4153-5 · Cited by 543
Aggarwal, S., Ichikawa, H., Takada, Y., Sandur, S. K., Shishodia, S., & Aggarwal, B. B. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.017400 · Cited by 532
Vascular endothelial growth factor and the regulation of angiogenesis.
Ferrara, N. (2000) · PubMed · Cited by 524
Bharti, A. C., Donato, N., & Aggarwal, B. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3863 · Cited by 508
Polymeric Micelles for Delivery of Poorly Water-Soluble Compounds
Kwon, G. S. (2003) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v20.i5.20 · Cited by 502 · cited 1×
“Conclusion In the course of the past decade, the field of drug delivery has been revolutionized with the advent of nanotechnology, wherein biocompatible nanoparticles have been developed as inert systemic carriers for therapeutic compounds to target cells and tissues [33-38].”
BackgroundShishodia, S., Amin, H. M., Lai, R., & Aggarwal, B. B. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.043 · Cited by 459
Combination Treatment With Curcumin and Quercetin of Adenomas in Familial Adenomatous Polyposis
Cruz–Correa, M., Shoskes, D. A., Sanchez, P., Zhao, R., Hylind, L. M., Wexner, S. D., & Giardiello, F. M. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.020 · Cited by 434
Garcea, G., Jones, D. J. L., Singh, R., Dennison, A. R., Farmer, P. B., Sharma, R. A., Steward, W. P., Gescher, A. J., & Berry, D. P. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601623 · Cited by 425
Effect of curcumin on normal and tumor cells: Role of glutathione and bcl-2
Syng-ai, C., Kumari, A. L., & Khar, A. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1101.3.9 · Cited by 395
AGGARWAL, B. B., & SHISHODIA, S. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1329.054 · Cited by 357
Multi-functional polymeric nanoparticles for tumour-targeted drug delivery
van Vlerken, L. E., & Amiji, M. M. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.2.205 · Cited by 352
Choudhuri, T., Pal, S., Das, T., & Sa, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410670200 · Cited by 321
Li, L., Aggarwal, B. B., Shishodia, S., Abbruzzese, J., & Kurzrock, R. (2004) · Cancer · doi:10.1002/cncr.20605 · Cited by 289
Park, S.-Y., & Kim, D. S. H. L. (2002) · Journal of Natural Products · doi:10.1021/np010039x · Cited by 278
Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines
Jiang, M., Yang‐Yen, H., Yen, J. J., & Lin, J. (1996) · Nutrition and Cancer · doi:10.1080/01635589609514468 · Cited by 275
Molecular genetics of pancreatic intraepithelial neoplasia
Feldmann, G., Beaty, R., Hruban, R. H., & Maitra, A. (2007) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-006-1166-5 · Cited by 269
Self-citationCancer risk and diet in India.
Sinha, R. R., Anderson, D. E., McDonald, S. S., & Greenwald, P. (2003) · PubMed · Cited by 266
Biological Effects of Curcumin and Its Role in Cancer Chemoprevention and Therapy
Singh, S., & Khar, A. (2006) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152006776930918 · Cited by 264
Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis
Chuang, S. E. (2000) · Carcinogenesis · doi:10.1093/carcin/21.2.331 · Cited by 253
Celecoxib and Curcumin Synergistically Inhibit the Growth of Colorectal Cancer Cells
Lev-Ari, S., Strier, L., Kazanov, D., Madar-Shapiro, L., Dvory-Sobol, H., Pinchuk, I., Marian, B., Lichtenberg, D., & Arber, N. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0171 · Cited by 221
Li, N., Chen, X., Liao, J., Yang, G., Wang, S., Josephson, Y., Han, C., Chen, J., Huang, M.-T., & Yang, C. S. (2002) · Carcinogenesis · doi:10.1093/carcin/23.8.1307 · Cited by 217
Khor, T. O., Keum, Y.-S., Lin, W., Kim, J.-H., Hu, R., Shen, G., Xu, C., Gopalakrishnan, A., Reddy, B., Zheng, X., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2708 · Cited by 203
Epidemiology of digestive tract cancers in India. V. Large and small bowel.
Mohandas, K. M., & Desai, D. C. (1999) · PubMed · Cited by 166
Mechanism of inhibition of benzo[a]pyrene-induced forestomach cancer in mice by dietary curcumin
Singh, S. (1998) · Carcinogenesis · doi:10.1093/carcin/19.8.1357 · Cited by 158
Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin
Ramachandran, C., & You, W. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006170224414 · Cited by 150
Deeb, D., Jiang, H., Gao, X., Hafner, M. S., Wong, H. K., Divine, G., Chapman, R., Dulchavsky, S. A., & Gautam, S. C. (2004) · PubMed · Cited by 141
Deeb, D., Jiang, H., Gao, X., Hafner, M. S., Wong, H., Divine, G., Chapman, R., Dulchavsky, S. A., & Gautam, S. C. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.803.3.7 · Cited by 131
Hidaka, H., Ishiko, T., Furuhashi, T., Kamohara, H., Suzuki, S., Miyazaki, M., Ikeda, O., Mita, S., Setoguchi, T., & Ogawa, M. (2002) · Cancer · doi:10.1002/cncr.10812 · Cited by 124
Inano, H. (1999) · Carcinogenesis · doi:10.1093/carcin/20.6.1011 · Cited by 118
Lev‐Ari, S., Zinger, H., Kazanov, D., Yona, D., Ben‐Yosef, R., Starr, A., Figer, A., & Arber, N. (2005) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(05)80045-9 · Cited by 80
Soni, S., Babbar, A. K., Sharma, R. K., & Maitra, A. (2006) · Journal of drug targeting · doi:10.1080/10611860600635608 · Cited by 79
Self-citationTyagi, R., Lala, S., Verma, A. K., Nandy, A. K., Mahato, S. B., Maitra, A., & Basu, M. K. (2005) · Journal of drug targeting · doi:10.1080/10611860500046732 · Cited by 70
Self-citationLipecka, J., Norez, C., Bensalem, N., Baudouin-Legros, M., Planelles, G., Becq, F., Edelman, A., & Davezac, N. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.097667 · Cited by 70
Homozygous deletions of methylthioadenosine phosphorylase in human biliary tract cancers
Karikari, C. A., Mullendore, M. E., Eshleman, J. R., Argani, P., Leoni, L. M., Chattopadhyay, S., Hidalgo, M. M., & Maitra, A. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0103 · Cited by 35
Self-citationSome like it hot: curcumin and CFTR
Davis, P. B., & Drumm, M. L. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.08.001 · Cited by 12
(2001) · PubMed
(2001) · PubMed
Cited by
Bioavailability of curcumin: Problems and promises
Anand, P., Kunnumakkara, A. B., Newman, R. A., & Aggarwal, B. B. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700113r · Cited by 5,543
Nanoparticle-based targeted drug delivery
Singh, R., & Lillard, J. W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.12.004 · Cited by 2,734
Curcumin as “Curecumin”: From kitchen to clinic
Goel, A., Kunnumakkara, A. B., & Aggarwal, B. B. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.016 · Cited by 2,214
Toxicity of lead: a review with recent updates
Flora, G., Gupta, D., & Tiwari, A. (2012) · Interdisciplinary Toxicology · doi:10.2478/v10102-012-0009-2 · Cited by 2,144
Sun, D., Zhuang, X., Xiang, X., Liu, Y., Zhang, S., Liu, C., Barnes, S., Grizzle, W., Miller, D., & Zhang, H.-G. (2010) · Molecular Therapy · doi:10.1038/mt.2010.105 · Cited by 1,572
Metadata
- Authors
- Bisht, S., Feldmann, G., Soni, S., Ravi, R., Karikar, C., Maitra, A., & Maitra, A.
- Venue
- Journal of Nanobiotechnology
- Published
- 2007-04-17
- Volume
- 5
- Issue
- 1
- Pages
- 3-3
- ISSN
- 1477-3155 (ISSN-L)
- OpenAlex
- W2115586774
- Cited by
- 1,090
- References
- 56
- FWCI
- 18.69
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.